CASE REPORT
Concomitant androgenetic alopecia and telogen effluvium
This is a case report conducted with the ETHEREA-MX® platform and ProDeep® handpiece..
Jurany Andrea Sánchez Bustamante, MD
Dermatologist
Medellín, Colombia
Alopecia is a chronic and progressive condition of genetic and hormonal origin, characterized by the miniaturization of hair follicles under the action of androgens, such as dihydrotestosterone (DHT), mainly affecting the frontal, parietal, and vertex regions.
Telogen effluvium, on the other hand, is a diffuse, sudden, and generally reversible hair loss caused by the premature entry of many follicles into the telogen phase, triggered by factors such as stress, illness, surgery, postpartum, nutritional deficiencies, medications, or hormonal changes.
In this case, the patient presented both conditions simultaneously. Treatments for alopecia and telogen effluvium involve a combined and individualized approach. Generally, they include topical therapies such as minoxidil, oral therapies, supplements, infiltrations, microneedling, photobiomodulation with LED, and, in specific situations, hair transplantation. The non-ablative Nd:YAP 1,340 nm laser appears to be an important complementary tool in these treatments, as it promotes controlled heating of the dermis, stimulates neocollagenesis, and improves local microcirculation, favoring follicular metabolism without hair breakage.
Clinically, the patient presented with rapid and abundant hair loss, with more pronounced thinning areas in the frontal and vertex regions. The ProDeep® Nd:YAP 1340 nm handpiece is compatible with the ETHEREA-MX® and ZYE® platforms. The patient underwent four sessions, one per month, using the technology with two passes over the entire affected area (avoiding overlap), combined with exosome administration.